Renal oncocytoma displaying intense activity on 18F-FDG PET

American Journal of Roentgenology

Volumn 186, Issue 1, 2006, Pages 269-270

  Blake, Michael A ^a   McKernan, Margaret ^a   Setty, Bindu ^a   Fischman, Alan J ^a   Mueller, Peter R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; HYSTERECTOMY; KIDNEY BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHADENOPATHY; NAUSEA; NEPHRECTOMY; ONCOCYTOMA; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SALPINGOOOPHORECTOMY; KIDNEY TUMOR; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ADENOMA, OXYPHILIC; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KIDNEY NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 33644838289     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.0110     Document Type: Article

References (4)

1. Aide N, Cappele O, Bottet P, et al. Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 2003; 30:1236-1245
2. Bachor R, Kotzerke J, Gottfried HW, Brandle E, Reske SN, Hautmann R. Positron emission tomography in diagnosis of renal cell carcinoma [in German]. Urologe A 1996; 35:146-150
3. Miyakita H, Tokunaga M, Onda H, et al. Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 2002; 9:15-18
4. Kang DE, White RL, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004; 171:1806-1809